Loading...
•
Sep 30, 2020
Jaguar Health Q3 2020 Earnings Report
Reported consolidated financial results for the third quarter of 2020.
Key Takeaways
Jaguar Health reported third quarter Mytesi net sales of approximately $2.8 million and gross sales of approximately $6.3 million. The increase in sales coincided with enhancements to the Mytesi patient access program, NapoCares™.
Mytesi net sales were approximately $2.8 million in Q3 2020.
Mytesi gross sales were approximately $6.3 million in Q3 2020.
Enhancements to the Mytesi patient access program, NapoCares™, coincided with the increase in sales.
Animal-related sales were minimal in Q3 2020 due to intentionally minimal commercialization efforts.